SCHEMBL19258601

SCHEMBL19258601

O=C(O)CCCCCc1ccc(CCCCC(=O)O)o1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.69
MAPT P10636 2/20 0.57
RXFP1 Q9HBX9 2/20 0.57
F13A1 P00488 3/20 0.52
LMNA P02545 3/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50
PMP22 Q01453 1/20 0.50
ALDH1A1 P00352 2/20 0.49
POLB P06746 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
PRNP P04156 1/20 0.49
RECQL P46063 1/20 0.49
PKM P14618 1/20 0.49
HTT P42858 1/20 0.49
HSD17B10 Q99714 1/20 0.49
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
NR4A2 P43354 1/20 0.47
PPARA Q07869 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17537910 1.00 EPHX2 (0.69) EPHX2MAPTRXFP1F13A1LMNA
SCHEMBL17537928 0.98 EPHX2 (0.66) EPHX2MAPTRXFP1F13A1LMNA
SCHEMBL17537934 0.93 EPHX2 (0.61) EPHX2MAPTRXFP1F13A1LMNA
SCHEMBL17537940 0.91 EPHX2 (0.58) EPHX2MAPTRXFP1LMNATSHR
SCHEMBL18642331 0.91 EPHX2 (0.73) EPHX2MAPTRXFP1LMNATSHR
SCHEMBL29236924 0.91 EPHX2 (0.83) EPHX2MAPTTSHRALDH1A1TDP1
SCHEMBL14054041 0.91 EPHX2 (0.83) EPHX2MAPTTSHRALDH1A1TDP1
SCHEMBL3506260 0.91 EPHX2 (0.83) EPHX2MAPTTSHRALDH1A1TDP1
SCHEMBL2703694 0.91 EPHX2 (0.83) EPHX2MAPTTSHRALDH1A1TDP1
SCHEMBL8087417 0.91 EPHX2 (0.83) EPHX2MAPTTSHRALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093939-A9 NOVEL MONOMERS FROM BIOMASS NDSU RESEARCH FOUNDATION (US) 2018-04-05 US disclosed
US-20170233325-A1 NOVEL MONOMERS FROM BIOMASS NDSU RESEARCH FOUNDATION (US) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093939-A9 NOVEL MONOMERS FROM BIOMASS DCXR, MANBA, PGLS EPHX2 2201/4885MAPT 1714/4885RXFP1 3989/4885
US-20170233325-A1 NOVEL MONOMERS FROM BIOMASS DCXR, MANBA, PGLS EPHX2 2201/4885MAPT 1714/4885RXFP1 3989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.